Study of ATTO-1310 for chronic itching of unknown cause
Part of Skin clinical trials.
This trial tests an investigational drug called ATTO-1310 to see if it can reduce chronic itching that has no clear cause. It may help people who have tried antihistamines without success.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 90 years old, weigh between 50 and 125 kg, and have a BMI between 18.5 and 40.
- You have had itching for at least 6 months that doctors cannot link to another condition or medication.
- The itching affects at least two of these areas: legs, arms, or trunk.
- You have tried at least one antihistamine in the past 6 months without enough relief.
- You rate your itching as 'severe' and have a weekly average itch score of 7 or higher on a 0-10 scale.
- You are willing to use a bland moisturizer twice daily for at least 2 weeks before starting the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an investigational medicine (remibrutinib) for people with severe itching that has no known cause. It may help reduce the itch when moisturizers haven't worked.
This study tests a new medicine called remibrutinib to see if it can reduce severe itching that has no clear cause. It aims to help people whose daily itching is very intense and not relieved by standard creams.
This Phase 3 study tests whether dupilumab injections can reduce severe itching that has no clear cause. It also checks how safe the medicine is over the study period.
This trial tests an experimental drug called ICP-332 for people with prurigo nodularis (a condition causing very itchy, hard bumps on the skin). It aims to see if the drug can safely reduce itching and improve skin lesions.
This study checks blood antibodies (BP180 and BP230) in people who develop long-lasting itching after starting immune therapy for cancer. It may help doctors understand why the itching happens and how it relates to autoimmune skin conditions.
This trial tests an investigational drug called MG-K10 for people with prurigo nodularis, a skin condition that causes intense itching and bumps. The goal is to see if it can help reduce itch and improve skin.
Hear when a new Chronic Pruritus of Unknown Origin trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.